1. RIG-I acts as a tumor suppressor in melanoma via regulating the activation of the MKK/p38MAPK signaling pathway. Hum Cell. Rui Guo, Shun-Yuan Lu, Jin-Xia Ma, Qian-Lan Wang, Lu Zhang, Ling-Yun Tang, Yan Shen, Chun-Ling Shen, Jin-Jin Wang, Li-Ming Lu, Zhu-GangWang, Hong-Xin Zhang:2022 Apr 13,，（Accepted）. 2. Tumor-infiltrating PD-L1+ Neutrophils Induced by GM-CSF Suppress T Cell Function in Laryngeal Squamous Cell Carcinoma and Predict Unfavorable Prognosis. Journal of Inflammation Research. Di Tang#, Duo Zhang#, Yu Heng, Xiao-ke Zhu, Han-qing Lin, Jian Zhou, Lei Tao*, and Li-ming Lu* 2022 Feb. 16;15:1079-1097 3. Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR- targeted therapy in lung cancer. Sci Transl Med 2021 Oct 6;13(614):eabg6428. Ke-Ren Zhang , Yu-Fei Zhang , Hui-Min Lei , Ya-Bin Tang , Chun-Shuang Ma , Qian-Ming Lv , Shi-Yi Wang , Li-Ming Lu , Ying Shen , Hong-Zhuan Chen , Liang Zhu. 4.Prognostic Impact of Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma Patients. Laryngoscope. 2020 Oct 27. doi: 10.1002/lary.29196. Duo Zhang; Di Tang; Yu Heng; Xiao-Ke Zhu; Liang Zhou; Lei Tao; Li-Ming Lu* 5.A systematic analysis identifies key regulators involved in cell proliferation and potential drugs for the treatment of human lung adenocarcinoma. Frontiers in Oncology-Thoracic Oncology. 2021 Sep 28;11:4-15. Kai Wang, Man Zhang, Jiao Wang, Jizhuang Luo, Pan Sun, Haizhen Jing, Rong Li, Changqing Pan, Li-Ming Lu*. 6. Dysregulation of DPP4-CXCL12 balance by TGF-β1/SMAD pathway promotes CXCR4+ inflammatory cell infiltration in keloid scars. Journal of Inflammation Research. 2021 Aug 26; 14:4169-4180. ZongAn Chen, Zhen Gao, LingLing Xia, XiaoQing Wang, Li-Ming Lu* XiaoLi Wu *.. 7. BCL11A promotes the progression of laryngeal squamous cell carcinoma. Frontiers in Oncology. 2020 Mar 20;10:375. doi: 10.3389/fonc.2020.00375. Jian Zhou, Liang Zhou, Duo Zhang, Wei-Jing Tang, Di Tang, Xiao-Ling Shi, Yue Yang, Lin Zhou, Fei Liu, Yong Yu, Pentao Liu, Lei Tao, Li-Ming Lu*. 8. CXCL8high inflammatory B cells in the peripheral blood of patients with biliary atresia are involved in disease progression. Immunology & Cell Biology. 2020; 1–11. Zhang Yu; Zhou Lin; Gu Xiang; Feng Xuan; Ding Ping; Xia Qiang; Li-Ming Lu* 9.Chidamide combined with paclitaxel effectively reverses the expression of histone deacetylase in lung cancer. Anti-Cancer Drugs. 2020 August; 31(7):702-708. Zhang, Na; Sun, Pan; Jin, Haizhen; Yang, Yuqin; Zhao, Qingya; Zhou, Lin; Guo, Lili; Yang, Xiaohua; Li-Ming Lu* 10. Link Between CIITA rs3087456 Polymorphism and the Risk of Laryngeal Squamous Cell Carcinoma in a Chinese Population. Pathol Res Pract. 2020 Jan;216(1):152793. Yi Xue , Di Tang , Sheng-Jie Li , Jian Zhou , Chi-Yao Hsueh , Dan-Dan Zhao , Yu Heng , Lei Tao, Li-Ming Lu* 11. IL-33 promotes the progression of nonrheumatic aortic valve stenosis via inducing differential phenotypic transition in valvular interstitial cells. Journal of cardiology. 2019 Aug 12. HeYu-Bin; GuoJiang-Hong; WangChong; Zhu Dan; Lu Li-Ming*. 12. PD-L1 and B7-1 Cis-Interaction: New Mechanisms in Immune Checkpoints and Immunotherapies. Trends Mol Med.2020 Nov 13;S1471-4914(20)30266 -5. Christopher D Nishimura, Marc C Pulanco, Wei Cui, Liming Lu, Xingxing Zang. 13. Mesothelin-targeted second generation CAR-T cells inhibit growth of mesothelin-expressing tumors in vivo. Exp Ther Med. 2019 Jan;17(1):739-747. Lin Ye, Yuqing Lou, Liming Lu* and Xiaohong Fan. 14. A Pathologic Complete Response to Neoadjuvant Chemotherapy and Immunotherapy Followed by Surgery in a Patient With NSCLC. Journal of Thoracic Oncology, 2019, 14(5): E104-E106.Ma, Xiao; Li, Bin; Li, Yuan; Lu, Liming; Chen, Haiquan 15. Correlation Between the NLRP3 Inflammasome and the Prognosis of Patients With LSCC. FRONTIERS IN ONCOLOGY , 2019 , Jul 2;9:588. Yi xue, Huai-Dong Du, Di Tang, Duo Zhang, Jian Zhou, Chang-Wen Zhai, Cun-Cun Yuan, Chi-Yao Hsueh, Sheng-Jie Li, Yu Heng, Lei Tao and Li-ming Lu*. 16. CXCL16/CXCR6 Is Involved in LPS-induced Acute Lung Injury via P38 Signaling. Cell Physiol Biochem. 2019; 00; 1-10. Guo-wei Tu ,Min-jie Ju, Yi-jun zheng, Guang-wei Hao,Guo-guang Ma, Jun-yi Hou, Xue-peng Zhang, Zhe Luo, Li-ming Lu*. 17. Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for non-small cell lung cancer therapy. European Respiratory Journal . 2019 Mar 1;53(3). pii: 1801562. doi: 10.1183/13993003.01562-2018. Jun Lu, Hua Zhong, Tianqing Chu, Xueyan Zhang, Rong Li, Jiayuan Sun, Runbo Zhong, Yuqin Yang, Mohammad Shah Alam, Yuqing Lou, Jianlin Xu, Yanwei Zhang, Jun Wu, Xiaowei Li, Xiaodong Zhao, Kai Li, Liming Lu*, Baohui Han. 18. CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease. Journal of J Neuroinflammation. 2019;16(1):263. Yuanyuan Li, Mengyue Niu, Aonan Zhao, Wenyan Kang, Zhichun Chen, Ningdi Luo, Liche Zhou, Xiongwei Zhu, Liming Lu* and Jun Liu*. 19. Establishment of porcine and human expanded potential stem cells. Nature cell biology, 2019, 21(6): 687. Gao, Xuefei; Nowak-Imialek, Monika; Chen, Xi; Chen, Dongsheng; Herrmann, Doris; Pei, Duanqing; Zhang, Yi; Lu, Liming; Yang, Fengtang; Kimber, Susan J; Ahmed, Asif; Yeung, William Shu Biu; Teichmann, Sarah A; Niemann, Heiner; Liu, Pentao. 20. SENP3 maintains the stability and function of regulatory T cells via BACH2 deSUMOylation. Nature communications, 2018, 9(1): 3157. Xiaoyan Yu, Yimin Lao, Xiao-Lu Teng, Song Li, Yan Zhou, Feixiang Wang, Xinwei Guo, Siyu Deng, Yuzhou Chang, Xuefeng Wu, Zhiduo Liu, Lei Chen, Liming Lu, Jinke Cheng, Bin Li, Bing Su, Jin Jiang, Hua-Bing Li, Chuanxin Huang, Jing Yi & Qiang Zou . 21. Metabolic control of regulatory T cell stability and function by TRAF3IP3 at the lysosome. J Exp Med .2018 Sep 3;215(9):2463-2476. doi: 10.1084/jem.20180397. Xiaoyan Yu, XiaoLu Teng, Feixiang Wang, Yuhan Zheng, Guojun Qu, Yan Zhou, Zhilin Hu, Zhongqiu Wu, Yuzhou Chang, Lei Chen,HuaBing Li, Bing Su, Liming Lu*, Zhiduo Liu, ShaoCong Sun, and Qiang Zou. 22. Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy. Scientific Reports,2018,8(1):3917 Dongfang Tang, Ruyong Yao, Dandan Zhao, Lin Zhou, Yun Wu, Yang Yang, Yifeng Sun, Liming Lu, Wen Gao 23. The miR-3127-5p/p-STAT3 axis up-regulates PD-L1 inducing chemoresistance in non-small-cell lung cancer .JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22(8): 3847-3856.Tang, Dongfang; Zhao, Dandan; Wu, Yun; Yao, Ruyong; Zhou, Lin; Lu, Liming*; Gao, Wen*; Sun, Yifeng* 24. Peptede TK-PQ induces immunosuppression in skin allogeneic transplantation via increasing Foxp3+ Treg and impeding nuclear translocation of NF-κB. Molecular Immunology. 2018 Sep;101:597-607. doi: 10.1016/j.molimm. Yue Wang, Qing Li, Lin Zhou, Xueping Ding, Li-ming Lu*. 25. Obesity or Overweight, a Chronic Inflammatory Status in Male Reproductive System, Leads to Mice and Human Subfertility. Frontiers in Physiology, 2018, 8:1117. doi: 10.3389/fphys. Weimin Fan, Yali Xu, Yue Liu , Zhengqing Zhang , Liming Lu* and Zhide Ding. 26. Characterization of Memory T Lymphocytes in Keloid Disease. Br J Dermatol. 2018 Apr;178(4):940-950. ZongAn Chen*, Lin Zhou*, TaeHao Won, Zhen Gao, XiaoLi Wu, Li-ming Lu*. 27. Genetic polymorphisms and plasma levels of BCL11A contribute to the development of laryngeal squamous cell carcinoma. PloS one, 2017 Feb 22;12(2):e0171116. Zhou, J., Yang, Y., Zhang, D., Zhou, L., Tao, L., & Lu L*. 28. Regulatory T Cells may Play an Protection Role in Lung Injury after Operation in Rheumatic Heart Disease. Journal of Thoracic Disease, 2018 Jun;10(6):3196-3205. Xiao-yang Zhang, Lin Zhou, Zhen Guo, Ye Kong, Wei Zhang, Li-ming Lu*,，Xin Li*. 29. Establishment of mouse expanded potential stem cells.[J] .Nature, 2017, 550(7676): 393-397. Yang Jian,Ryan David J,Wang Wei, Jason Cheuk-Ho Tsang, Guocheng Lan, Hideki Masaki, Xuefei Gao, Liliana Antunes, Yong Yu, Zhexin Zhu, Juexuan Wang, Aleksandra A. Kolodziejczyk, Lia S. Campos, Patrick P. L. Tam, Hiromitsu Nakauchi, Xiangang Zou, Liming Lu & Pentao Liu*. 30. Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma.[J] .Oncol Lett, 2017, 14(1): 561-568. Tang Wei-Jing,Tao Lei, Li-ming Lu* . 31. Association of the recurrence of vocal leukoplakia with MDM2-309 variants over a 2-year period: a prospective study. Acta Otolaryngol, 2016.136, 95-9. Zhou, J, Y. Yang, D. Zhang, L. Zhou, F. Liu, L. Tao, Lu L*. 32. Objective measurement and significance of PD-L1, B7-H3, B7-H4 and TILs in small cell lung cancer (SCLC). Journal of Clinical Oncology, 2016, 34: 8566-8566. Kurt Alex, Schalper; Daniel E., Carvajal-Hausdorf; Joseph Francis, McLaughlin; Mehmet, Jie, Zhang, Liming Lu, Baohui, Han, Hui, Lu. 33. Association of the recurrence and canceration rate of vocal leukoplakia with interleukin-10 promoter variants over a 2-year period. Acta Otolaryngol, 2016. 136, 1147-1153. ZhouJ, D.Zhang, L. Zhou, Y. Yang, F. Liu, L. Tao, Lu L* 34. New insights into myeloid-derived suppressor cells and their roles in feto-maternal immune cross-talk. J Reprod Immunol. 2015 Nov 10;113:35-41. doi: 10.1016/j.jri.2015.11.001. Zhao AM, Xu HJ, Kang XM, Zhao AM, Lu. L* .. 35. The ratio of CD4/CD8 T-cells in human papillomavirus-positive laryngeal squamous cell carcinoma accounts for improved outcome. Acta Otolaryngol, 2016.136, 826-33. Zhang, D, W. J. Tang, D. Tang, J. Zhou, L. Chou, L. Tao &Lu L* 36. Neutrophil infiltration mediated by CXCL5 accumulation in the laryngeal squamous cell carcinoma microenvironment: A mechanism by which tumour cells escape immune surveillance. Clinical Immunology, 2017, 175: 34-40. Zhang D, Zhou J, Tang D, Lei Tao, Lu L*. 37. Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its developmental pathway. Nature. 2016 Sep; 539(7627). Yu, Y, Tsang, C-H. J, Wang, C, Simon Clare, Juexuan Wang,Xi Chen, CordeliaBrandt, Leanne Kane, Lia S. Campos, Lu Lu*, Gabrielle T. Belz, Andrew N. J. McKenzie,Sarah A.Teichmann, Gordon Dougan& Pentao. 38. Association of the microsatellite (GT)n repeat polymorphisms of the HO-1 gene promoter and corresponding serum levels with the risk of laryngeal squamous cell carcinoma. Acta Otolaryngol, 2016. 136, 806-11. Tang, D, W. J. Tang, X. L. Shi, W. P. Li, H. Zhou, Lu L*, L. Tao. 39. Low concentration of Trichosanthin induces apoptosis and cell cycle arrest through JNK/MAPK activation. Molecular Medicine Report. 2015 Jan;11(1):349-56. doi: 10.3892/mmr. Zhang D, Chen B, Zhou J, Zhou L, Li Q, Liu F, Chou KY, Tao L, Lu L*. 40. The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development. The Journal of experimental medicine 2015; 212:865-74. Yu Y, Wang C, Clare S, Wang J, Lee SC, Brandt C, Burke S1, Lu L*, He D, Jenkins NA, Copeland NG, Dougan G, Liu P.. 41. Signalling Through Retinoic Acid Receptors is Required for Reprogramming of Both Mouse Embryonic Fibroblast Cells and Epiblast Stem Cells to Induced Pluripotent Stem Cells. Stem Cells. 2015 May 33(5):1390-404. doi: 10.1002/stem.1926. Yang J, Wang W, Ooi J, Campos LS, Lu L*, Liu P 42. A peptide tetramer Tk-tPN induces tolerance of cardiac allografting by conversion of type 1 to type 2 immune responses via the Toll‐like receptor 2 signal‐promoted activation of the MCP1 gene. Immunology, 2016, 147(3): 355-366. Li Z, Yang N, Zhou L, Lu L*, Chou KY. 43. Single-cell transcriptomic reconstruction reveals cell cycle and multi-lineage differentiation defects in Bcl11a-deficient hematopoietic stem cells. Genome Biol. 2015 Sep 21;16(1):178. doi:10.1186/s13059-015-0739-5. Tsang JC, Yu Y, Burke S, Buettner F, Wang C, Kolodziejczyk , Teichmann SA, Lu L*, Liu P, 44. Significance of MDM2-309 polymorphisms and induced c orresponding plasma MDM2 levels in susceptibility to laryngeal squamous cell carcinoma.DNA Cell Biol. 2014 Feb;33(2):88-94. Zhou J, Liu F, Zhang D, Chen B, Li Q, Zhou L, Lu L*, Tao L. 45. Association of interleukin?10 promoter polymorphisms and corresponding plasma levels with susceptibility to laryngeal squamous cell carcinoma ONCOLOGY LETTERS 2014,7:1721-1727. Jian Zhou, Duo Zhang, Bin Chen, Qing Li, Lin Zhou, Fei Liu, Kuang-Yen Chou, Lei Tao, Lu L*. 46. A Trichosanthin-derived peptide suppresses type 1 immune responses by TLR2-dependent activation of CD8+CD28?Tregs Clinic immunology (2013), 153, 277–287. Neng Yang, Zuoqing Li, Zhijun Jiao, Peng Gu, Yun Zhou, Lu.L*, Kuang-Yen Chou 47. Genetic polymorphism and plasma levels of interleukin-22 contribute to the development of nonsmall lung cancer. DNA and CellBiology. 2014 Oct;33(10):705-14. doi: 10.1089/dna. F. Liu, X. Pan, L. Zhou, B. Chen, J. Shi, W. Gao and Lu. L*. 48. Cellular reprogramming by transcription factor engineering. Current Opinion in Genetics & Development 2014, 28:1–9. Tsang JC, Xuefei Gao, Lu. L*, Pentao Liu 49. Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers. Nucleic Acids Research, 2014 doi: 10.1093/nar/gku836. Xuefei Gao, Jason C.H. Tsang, Fortis Gaba, Donghai Wu, Lu L*, Pentao Liu 50. High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma. ONCOLOGY REPORTS 2013 30: 1380-1390. Bin Chen, Duo Zhang, Jian Zhou, Qing Li, Lin Zhou, Shi-Min Li, Li Zhu, Kuang-Yen Chou, Liang Zhou, Lei Tao, Lu L*, 51. Mutated MHC class II transactivator upregulates IL-33-dependent differentiation of Th2 subset through Nod2 binding for NLR signaling initiation. Journal of Biological Chemistry, 2012 Mar 23;287(13) :9972-9981. Yang ZQ, Yang N, Zhou Y, Xin LJ, Lu L*, Chou KY. 52. Con A-binding protein Zn-α2-glycoprotein on human sperm membrane is related to acrosome reaction and sperm fertility. International Journal of Andrology. 2012 Apr;35(2):145-157. Liu Y, Qu F, Cao X, Chen G, Guo Q, Ying X, Guo W, Lu L*, Ding Z. 53. Human PD-L1-overexpressing porcine vascular endothelial cells induce functionally suppressive human CD4+CD25hiFoxp3+ Treg cells. Journal ofLeukocyte Biology , 2011 Jul, 90 (1):77-86. Ding Q, Lu L, Xiaorong Zhou, Zhou Y, Chou KY. Co-first author 54. Phenotypic alterations of dendritic cells are involved in suppressive activity of trichosanthin-induced CD8+CD28- regulatory T cells. Journal of Immunology. 2010 Jul 1: 185(1):79-88. Wang B, Jiao Z, Shao X, Lu L, Yang N, Zhou X, Xin L, Zhou Y, Chou KY. 55. High level expression of B7H1 molecules by keratinocytes suppresses xeno- and allo- eactions by inducing type I regulatory T cells TransplantImmunology, 2009, 21: 192-197. Zhou XR, Zhou Y, Ding Q, Lu L, Yang N, Chou KY. 56. Up-regulation of IL-10 expression in dendritic cells is involved in Trichosanthin-induced immuno- suppression. Immunol Let 2007, 74-81. Zhou XR, Yang N, Lu L, Ding Q, Jiao ZJ, Zhou Y, Chou KY. 57. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation. Immunol, 2007,122,476-485. Xiaorong Zhou,YangJiang, Lu L, Qing Ding,Kuang-Yen Chou. 58. 宣彬彬,丁旭蘋,侯亞菲,王雪,武嬌祥,孫寒曉,譚美玉,盛慧明,路麗明.天花粉蛋白通過影響Foxp3的泛素化水平增強CD4+Treg的體外誘導的初步研究. 現(xiàn)代免疫學. 2022, 42（3）:185-192 59. 林瀚青,陶磊,路麗明. CD4+調節(jié)性T細胞：功能異質性、分群與疾病. 現(xiàn)代免疫學. 2022年02期488-492. 60. 楊曉華,郭莉莉,路麗明*.耐紫杉醇肺原位小鼠移植瘤模型的建立和鑒定.中國實驗動物學報2021年03期:275-283頁 61. 丁旭萍,王雪,路麗明*.中藥天花粉蛋白增強誘導CD4+CD25+Foxp3+調節(jié)性 T細胞數(shù)量和功能的初探. 世界科學技術-中醫(yī)藥現(xiàn)代化. 網(wǎng)絡首發(fā)時間：2021-12-15. 62. 湯成捷,疏龍強,吳緣開,趙良娟,張亦凡,侯亞菲,路麗明*.中性粒細胞的免疫抑制亞群及功能和機制研究進展.細胞與分子免疫學雜志, 2020年09期:833-842頁 63. 費騰,李從鎮(zhèn),路麗明*.TIM-3分子與腫瘤免疫抑制. 中國腫瘤生物治療雜志 2020,27(02),199-203 DOI:10.3872/j.issn.1007-385x.2020.02.015 64. 薛乙,湯迪,翟長文,袁存存,衡宇,周梁,陶磊, 路麗明* CⅡTA表達與喉鱗狀細胞癌（LSCC）患者預后的關系.復旦學報(醫(yī)學版). 2020年02期 第192-196. 65. 商占仙, 路麗明*中性粒細胞在腫瘤發(fā)生,、發(fā)展中的研究進展. 現(xiàn)代免疫學. 2018年06期488-492. 66. 李健,郭震, 路麗明*,李欣.無血預充大鼠體外循環(huán)模型的建立[J].中國體外循環(huán)雜志,2018,16(03):184-188. 67. 陳廣潔, 謝長宜, 鈕曉音, 蔣黎華, 聶紅, 路麗明, 席曄斌, 葛海良. 機體防御與免疫整合課程的實踐與研究[J]. 中國高等醫(yī)學教育, 2018 (4): 16-17. 68. 衡宇, 查亞芳, 顧燕妮, 沈朝斌,，路麗明*. 2018 年美國兒童預防接種最新指南解讀及其與我國現(xiàn)狀比較. 現(xiàn)代免疫學, 2018, 38(04): 350-353. 69. 張曉陽，路麗明*,，李 欣 調節(jié)性T 細胞和輔助性T細胞與體外循環(huán)后肺損傷相關性的研究 中國體外循環(huán)雜志 2017,15:81-85 70. 萬建偉,，周琳，趙丹丹,，楊玉琴,，路麗明* 聯(lián)烯化合物 PHPO 對肺癌細胞株 A549 增殖及凋亡的影響 上海交通大學學報（醫(yī)學版）2017,37:1433-1439 71. 那君 楊小茜 胡婧雯胡敏娟 衡宇 路麗明* 細胞因子來源的天然蛋白質作為人類疫苗佐劑的研究進展 現(xiàn)代免疫學 2016, 36:337-340 72. 周琳 高文 路麗明* 肺移植后閉塞性細支氣管炎免疫學發(fā)病機制及治療新策略 現(xiàn)代免疫學 2016, 36:67-71 73. 楊小茜 胡婧雯 那君 胡敏娟 衡宇 路麗明* 非細胞因子來源的天然蛋白質作為人類疫苗佐劑的研究進展 現(xiàn)代免疫學 2016, 36:245-249 74. 胡敏娟 那君 胡婧雯 楊小茜 衡宇 路麗明* 病原生物相關蛋白作為人類疫苗佐劑的研究進展 現(xiàn)代免疫學 2016, 36:242-244 75. 邵曉軼, 馬妍慧, 路麗明*等. B7H1-lg 誘導 Tr1 細胞向 CD4+CD25+ Foxp3+ Treg 細胞轉化的研究. 現(xiàn)代免疫學, 2012, 6: 001. 76. 周琳，劉菲,，周光炎,，路麗明* 天花粉蛋白對結腸癌細胞株 CMT-93 凋亡及增殖的影響 上海交通大學學報（醫(yī)學版） 2014,34(3):257-262. 通訊作者 77. 劉菲, 潘旭峰, 周琳, 路麗明* 肺腺癌患者血漿 microRNA-10b 表達及臨床意義. 中華實用診斷與治療雜志, 2014, 28(9): 846-848. 78. 劉菲, 周光炎, 路麗明*. 胞內模式識別受體 NLR 的生物學特性及其在疾病中的作用[J]. 中國免疫學雜志, 2014, 12: 032. 79. 沈玥, 路麗明* 錢盈盈. Klotho 基因真核表達載體的構建及其 TCMK-1 細胞中的穩(wěn)定表達. 上海交通大學學報（醫(yī)學版） , 2014,34(5):567-572. 80. 劉菲 徐藝 周光炎 路麗明* CD8+Treg 的免疫生物學特征及其與疾病的關系 現(xiàn)代免疫學 2014, 34:61-66 通訊作者 81. 周琳,周光炎, 路麗明*.輔助性T細胞亞群的多樣性與分化的可塑性研究[J].中國免疫學雜志,2013,29(06):653-656. 82. 邵曉軼, 路麗明*, 周蕓, 等. 小鼠膜型 B7-H1 分子激活同種異體 Tr1 細胞介導免疫抑制. 南通大學學報: 醫(yī)學版, 2012, 32(5): 333-337. 83. 李青 周光炎 路麗明* 天花粉蛋白抑制同種異體混合淋巴細胞反應與誘導 IL9+IL10+IL24+Th9 細胞間關系的初步探討。現(xiàn)代免疫學 2012, 32(2): 94-98 通訊作者 84. 張鐸,，陶磊,，路麗明* 天花粉蛋白誘導腫瘤細胞凋亡和其它抗腫瘤作用機制及研究進展。復旦大學學報（醫(yī)學版）。 2012,， 39（ 6）： 663-667 通訊作者 85. 邵曉軼, 周蕓, 路麗明*. p38 MAPK 信號通路在 B7H1-Ig 融合蛋白誘導 Tr1 細胞分化中的作用.上海交通大學學報 (醫(yī)學版), 2012, 32(11): 1448. 86. 周琳 周光炎路麗明* IL-10 的雙向免疫調節(jié)作用 細胞與分子免疫學雜志,2012,28(10):1100-1102. 87. 陳斌 陶磊 周梁 周光炎 路麗明* CD4+CD25+Foxp3+Treg 細胞與喉癌發(fā)病的相關研究 現(xiàn)代免疫學 2012, 32: 40-46 通訊作者 88. 李青 周光炎 路麗明* Th9：亞群特征,、相關轉錄因子及其分化的可塑性。現(xiàn)代免疫學 2011,31:340-343 通訊作者 89. 李青 周光炎 路麗明* IL-9 的研究進展,。中國免疫學雜志 2011, 27:848-850 通訊作者 90. 陳斌,路麗明,陶磊,周梁,李詩敏,朱莉.趨化因子受體CCR6及CCR7在喉鱗狀細胞癌中表達的研究[J].臨床耳鼻咽喉頭頸外科雜志,2010,24(21):975-979. 91. 路麗明 丁慶 揚能 周蕓 周光炎,應用 RNA 干擾阻抑小鼠 L929 細胞 MHC II 類基因表達及功能的研究,，現(xiàn)代免疫學 2009, 28(6): 387-392 92. 周蕓,焦志軍,辛利軍,汪四七,路麗明,丁慶,周曉榮,楊能,周光炎.自體角朊細胞通過B7-H1介導對異種混合淋巴細胞增殖的抑制作用[J].現(xiàn)代免疫學,2009,29(06):486-490. 93. 王慧，楊能,，周佩軍，邵琨,，趙菊平,，徐達，王祥慧,，沈周俊,， 路麗明，劉世雄 混合培養(yǎng)的供,、受者骨髓細胞過繼回輸延長小鼠移植心臟存活時間 , 中華器官移植雜志 2009, 30:604-607 94. 周蕓 焦志軍 路麗明 丁慶 揚能 周光炎 自體角朊細胞通過誘導分泌 IL-10 的 T 細胞亞群抑制異種混合淋巴細胞增殖反應,，現(xiàn)代免疫學 2009, 29:387-391 95. 路麗明 丁慶 揚能 周蕓 周光炎 膜型 B7-H1 分子誘導產(chǎn)生的 T 細胞及其免疫學特性的初步研究，現(xiàn)代免疫學 2008, 28(6):465-469 96. 楊能,，路麗明,，周蕓，周曉榮,，焦志軍,，馬妍慧，周光炎 天花粉蛋白合成肽通過激活抑制性 CD8+T細胞誘導免疫抑制現(xiàn)代免疫學 2008,28(1). 16-20 97. 楊能,史桂英,路麗明,周蕓,馬妍慧,周光炎.天花粉蛋白合成肽通過誘導CD8抑制性T細胞治療實驗性自身反應性腦脊髓炎[J].現(xiàn)代免疫學,2008(03):199-202. 98. 辛利軍,焦志軍,丁慶,路麗明,周蕓,周光炎.B7-H1協(xié)同刺激淋巴細胞增殖并誘導產(chǎn)生抑制性T細胞[J].中國免疫學雜志,2007(08):680-683+687. 99. 路麗明,，丁慶,，江陽等 一種新的 CIITA 顯性負向突變體的構建和功能研究 現(xiàn)代免疫學 2006,26:116-120 100. 丁慶，路麗明,，江陽等 小鼠B7H1-Ig融合蛋白誘導免疫抑制的機制研究?，F(xiàn)代免疫學 2006,24(6). 460-463 101. 焦志軍，王保龍,，路麗明,，丁慶，周曉榮,，江陽,，周蕓，辛利軍,，周光炎,，天花粉蛋白對不同小鼠品系 T 細胞亞群分化的影響現(xiàn)代免疫學 2006,24(1). 12-16 102. 焦志軍，周蕓，辛利軍,，路麗明,，丁慶，周曉榮,，楊能,，周光炎天花粉蛋白及其肽段誘導的免疫抑制依賴 APC 表面 Notch 配體的表達現(xiàn)代免疫學 2006,26(6). 448-453 103. 焦志軍 周蕓 路麗明 丁慶 周曉榮 楊能 辛利軍 周光炎 天花粉蛋白免疫抑制作用的功能性肽段篩選及其作用機制現(xiàn)代免疫學 2006,26(5). 362-366 104. 曹聰 董英海 董宇啟 路麗明 崔磊 劉偉 曹誼林 人血源性間充質干細胞培養(yǎng)與體外成骨研究中國修復重建外科雜志 2005,19(8).642-647 105. 周洪語 路麗明 王勇 江基堯 羅其中欖香烯抑制腦膠質瘤細胞增殖的比較研究 中國實驗外科雜志 2004,21(10).1241-1243 106. 陳煒 劉偉 劉德莉 吳娟娟 路麗明 曹誼林 FasL 基因轉染 Hela 細胞體外誘導淋巴細胞凋亡的作用上海第二醫(yī)科大學學報 2004,24(4).279-283 107. 范華驊 郭榮 崔磊 劉偉 路麗明 曹誼林 CIITA 反義基因體外轉染對 HLA-Ⅱ類抗原表達的抑制作用的研究中國臨床醫(yī)學.2004,11(2).174-176 108. 江陽 路麗明 丁慶等 Ⅳ型Ⅱ類反式激活因子基因新變異體的克隆、鑒定和功能測定 現(xiàn)代免疫學2004,24(6).-460-463 109. 李寧麗 路麗明 等重組人可溶性 TRAIL 分子誘導細胞凋亡機理探討,。 上海第二醫(yī)科大學學報2003,23(1).10-14 110. 路麗明 李寧麗 沈佰華等 TRAIL 分子胞外區(qū)基因工程蛋白的制備與鑒定,，中國實驗診斷學2003,7； 477-479 111. 周洪語 路麗明 羅其中 SD大鼠星形膠質細胞的原代培養(yǎng) 中華神經(jīng)醫(yī)學雜志.2003,2(5). 346-347 112. 路麗明 李寧麗等 人可溶性TRAIL 基因的克隆及表達 上海免疫學雜志 2002, 22：308-312 教學論文： 1. Improvement of clinical medical students' comprehensive quality by the undergraduate innovative experimentation program; a teaching exploration. Clin Med Educ. Vol 3. No3,4. June 2016. Jinwen Hu, Xiaoqian Yang, Jun Na, Liming Lu. 2. RBL教學對臨床醫(yī)學本科生綜合能力培養(yǎng)的作用,，中華醫(yī)學教育探索雜志,，2016年10月，第15卷,，第10期. 于浩然,，張柳蕙，劉威,，周琳,，丁旭蘋，蔣黎華,，路麗明,。 3. 機體防御與免疫整合課程的實踐與研究，中國高等醫(yī)學教育,，2018年4月
參編教學專著： 1. 《人體健康與免疫科普叢書》嬰幼兒篇,，人民衛(wèi)生出版社，副主編,。 2. 《免疫學原理》-教育部指定研究生教材,，科學出版社，參編 3. 《Medical Immunology》-國家級規(guī)劃教材,，清華大學出版社,，參編 4. 《醫(yī)學免疫學與免疫學檢驗》國家級規(guī)劃教材，科學出版社,，參編 5. 《口腔臨床免疫學》第二版 國家級規(guī)劃教材,，人民衛(wèi)生出版社，參編 6. 《Immunobiology》中文版,，科學出版社,，副主編
|
